Peptide Sample Analysis Using EternityXT

Chromatography

Peptide Sample Analysis Using EternityXT

16 Mar, 2018

Published over 8 years ago. See the latest and most current information on Chromatography.

The peptide therapeutic market continues to develop fast where pharmaceutical companies focus in these types of compounds for large number of diseases. Chromatography plays an important role across the entire drug development cycle. Kromasil EternityXT, chemically stable merged inorganic/organic silica material for reversed phase chromatography, is a perfect material to be used from analysis to scale up of peptides.

With excellent mechanical and chemical stability, the Kromasil EternityXT materials offer first-rate separation power as well as loadability at low, medium and high pH. EternityXT columns are provided in 1.8 µm particles for UHPLC, 2.5 µm particles for both UHPLC and HPLC applications and finally 5 µm particles for HPLC and semipreparative chromatography. The C18 and C8 chemistries are also available in bulk for purification. The Kromasil EternityXT columns are based on patented technology, resulting from 30 years of expertise and used by chromatographers worldwide.

Latest News

ILM 51.6 Sept 2026

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Envirotech Online
Direct mercury analysis: Weighing the cost and productivity benefits
Explore more Arrow
Pollution Solutions Online
Vacuum technology enables efficient lithium-ion battery recycling with recovery rates of up to 95%
Explore more Arrow
Petro Online
The expanding role of high-temperature, high-shear viscometry in modern engine oil development
Explore more Arrow
Chromatography Today
Bacterial enzyme discovery reveals novel route to study antimicrobial resistance
Explore more Arrow